Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > LATEST
LATEST
-
REGULATORY Panel Backs Extra Charges for OTC-Like Drugs While Keeping Coverage, but Design Details Still Divisive
November 28, 2025
-
BUSINESS Insmed Japan to Double Sales Force with Brensocatib Launch on the Horizon
November 28, 2025
-
BUSINESS Chugai’s Market Cap Tops 14 Trillion Yen, Eyes Further Growth through “Co-Creation”: CEO
November 28, 2025
-
REGULATORY As Skepticism Emerges, LDP Health Policy Chief Seeks Stronger R&D Tax Credits
November 28, 2025
-
BUSINESS Teijin to Receive US$5 Million Milestone as Narcolepsy Drug Enters European PI
November 28, 2025
-
BUSINESS Izervay, Vorzzz, Dormicum Syrup Now Available in Japan
November 28, 2025
-
ORGANIZATION Wholesalers Urge Caution on Debating 2% Buffer without Bigger Reform Picture
November 28, 2025
-
ORGANIZATION Labor Federation Files Request for 5% Drug Price Hike with Health Minister
November 28, 2025
-
REGULATORY Japan Doles Out Orphan Tags to IgAN Drugs and Lots More
November 28, 2025
-
BUSINESS Meiji Seeks Label Expansion for Laserphyrin in Cervical Intraepithelial Neoplasia
November 28, 2025
-
BUSINESS Jardiance Tops 7 Categories in October Promotion Rankings: Intage
November 28, 2025
-
COLUMN AI in HR: Navigating the Ethical Minefield
November 28, 2025
-
REGULATORY New Govt Casts Pharma as Core Industry, Minister Says at Public-Private Confab
November 27, 2025
-
REGULATORY MHLW Floats Prefectural Bodies for Regional Formularies, LLP Copay Hike Gains Traction: LDP-Ishin Talks
November 27, 2025
-
BUSINESS Otsuka’s Sibeprenlimab Earns FDA’s Accelerated Nod for IgAN
November 27, 2025
-
REGULATORY MHLW Orders Label Revisions for Anticoagulants, Ondexxya, Tracleer, and More
November 27, 2025
-
BUSINESS Japan PIII Trial Begins for Kagoshima University Spinout’s Oncolytic Virus
November 27, 2025
-
REGULATORY Lawmakers Hold Cross-Party Study Session on Social Security
November 27, 2025
-
BUSINESS Mochida, Ayumi Curb Shipments of Humira Biosimilar 40 mg amid Surging Orders
November 27, 2025
-
BUSINESS Toray Out-Licenses Peripheral Neuropathy Drug to Sanodyne
November 27, 2025
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…